Showing results (131-140 of 182) with videos related to
Sort By:
Pageof 19
Surgery|October 13, 2015
Blood measurement of neuroendocrine gene transcripts defines the effectiveness of operative resection and ablation strategiesIrvin M Modlin, Andrea Frilling, Ronald R Salem, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 18, 2005
Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogsDik J Kwekkeboom, Jan Mueller-Brand, Giovanni Paganelli, et al.Cancer Biotherapy & Radiopharmaceuticals|February 19, 2004
In vivo and in vitro detection of dopamine d2 receptors in uveal melanomasLisa Bodei, Leo J Hofland, Diego Ferone, et al.Neuroendocrinology|October 4, 2018
Unmet Needs in Functional and Nonfunctional Pancreatic Neuroendocrine NeoplasmsRobert T Jensen, Lisa Bodei, Jaume Capdevila, et al.European Journal of Nuclear Medicine and Molecular Imaging|February 17, 2020
Lessons from a multicentre retrospective study of peptide receptor radionuclide therapy combined with lanreotide for neuroendocrine tumours: a need for standardised practiceVikas Prasad, Raj Srirajaskanthan, Christos Toumpanakis, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2019
Phase I Trial of Well-Differentiated Neuroendocrine Tumors (NETs) with Radiolabeled Somatostatin Antagonist <sup>177</sup>Lu-Satoreotide TetraxetanDiane Reidy-Lagunes, Neeta Pandit-Taskar, Joseph A O'Donoghue, et al.Insights Into Imaging|February 9, 2026
Precision imaging and evolving therapies in paragangliomas and pheochromocytomas: from molecular diagnostics to imaging-guided managementAurelie Choucair, Anna Zdunek, Matthew Liao, et al.Gut|March 11, 2021
Treatment of advanced gastroenteropancreatic neuroendocrine neoplasia, are we on the way to personalised medicine?Anja Rinke, Christoph J Auernhammer, Lisa Bodei, et al.Endocrine|February 7, 2024
Peptide receptor radionuclide therapy with 177Lu- or 90Y-SSTR peptides in malignant pheochromocytomas (PCCs) and paragangliomas (PGLs): results from a single institutional retrospective analysisManila Rubino, Giuseppe Danilo Di Stasio, Lisa Bodei, et al.European Journal of Nuclear Medicine and Molecular Imaging|December 16, 2019
PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETestLisa Bodei, Mark S Kidd, Aviral Singh, et al.Pageof 19